These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37255585)

  • 1. Supply chain planning of vaccine and pharmaceutical clusters under uncertainty: The case of COVID-19.
    Kochakkashani F; Kayvanfar V; Haji A
    Socioecon Plann Sci; 2023 Jun; 87():101602. PubMed ID: 37255585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal planning of the COVID-19 vaccine supply chain.
    Georgiadis GP; Georgiadis MC
    Vaccine; 2021 Aug; 39(37):5302-5312. PubMed ID: 34373118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A socio-economic optimization model for blood supply chain network design during the COVID-19 pandemic: An interactive possibilistic programming approach for a real case study.
    Tirkolaee EB; Golpîra H; Javanmardan A; Maihami R
    Socioecon Plann Sci; 2023 Feb; 85():101439. PubMed ID: 36164508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel approach for inventory problem in the pharmaceutical supply chain.
    Candan G; Yazgan HR
    Daru; 2016 Feb; 24():4. PubMed ID: 26912354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-echelon dynamic cold chain for managing vaccine distribution.
    Manupati VK; Schoenherr T; Subramanian N; Ramkumar M; Soni B; Panigrahi S
    Transp Res E Logist Transp Rev; 2021 Dec; 156():102542. PubMed ID: 34815731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new vaccine supply chain network under COVID-19 conditions considering system dynamic: Artificial intelligence algorithms.
    Kamran MA; Kia R; Goodarzian F; Ghasemi P
    Socioecon Plann Sci; 2023 Feb; 85():101378. PubMed ID: 35966449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing a sustainable-resilient-responsive supply chain network considering uncertainty in the COVID-19 era.
    Moadab A; Kordi G; Paydar MM; Divsalar A; Hajiaghaei-Keshteli M
    Expert Syst Appl; 2023 Oct; 227():120334. PubMed ID: 37192999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the COVID-19 cold chain vaccine distribution network with medical waste management: A robust optimization approach.
    Ensar Işık E; Topaloglu Yildiz S
    Expert Syst Appl; 2023 Nov; 229():120510. PubMed ID: 37251535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convalescent plasma bank facility location-allocation problem for COVID-19.
    Manupati VK; Schoenherr T; Wagner SM; Soni B; Panigrahi S; Ramkumar M
    Transp Res E Logist Transp Rev; 2021 Dec; 156():102517. PubMed ID: 34725541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stochastic Inventory Model for Minimizing Blood Shortage and Outdating in a Blood Supply Chain under Supply and Demand Uncertainty.
    Shih H; Rajendran S
    J Healthc Eng; 2020; 2020():8881751. PubMed ID: 32952991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust possibilistic programming to design a closed-loop blood supply chain network considering service-level maximization and lateral resupply.
    Momenitabar M; Dehdari Ebrahimi Z; Arani M; Mattson J
    Ann Oper Res; 2022 Sep; ():1-43. PubMed ID: 36157977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty.
    Shiri M; Ahmadizar F
    J Ambient Intell Humaniz Comput; 2022 Jun; ():1-25. PubMed ID: 35692508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing a sustainable closed-loop supply chain network of face masks during the COVID-19 pandemic: Pareto-based algorithms.
    Tirkolaee EB; Goli A; Ghasemi P; Goodarzian F
    J Clean Prod; 2022 Jan; 333():130056. PubMed ID: 34924699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-stage supply chain disruption mitigation strategy considering product life cycle during COVID-19.
    Chen J; Wang H; Fu Y
    Environ Sci Pollut Res Int; 2022 Feb; ():1-15. PubMed ID: 35124776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-objective programming and Six Sigma approaches for a competitive pharmaceutical supply chain with the value chain and product lifecycle.
    Shakouhi F; Tavakkoli-Moghaddam R; Baboli A; Bozorgi-Amiri A
    Environ Sci Pollut Res Int; 2022 Jun; ():. PubMed ID: 35748988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing a sustainable reverse supply chain network for COVID-19 vaccine waste under uncertainty.
    Amani Bani E; Fallahi A; Varmazyar M; Fathi M
    Comput Ind Eng; 2022 Dec; 174():108808. PubMed ID: 36405560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing a new multi-echelon multi-period closed-loop supply chain network by forecasting demand using time series model: a genetic algorithm.
    Safaei S; Ghasemi P; Goodarzian F; Momenitabar M
    Environ Sci Pollut Res Int; 2022 Nov; 29(53):79754-79768. PubMed ID: 35244850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing supply chain resilience through efficient redundancy allocation: a risk-averse mathematical model.
    Riccardo A; Daria B; Dmitry I
    IFAC Pap OnLine; 2021; 54(1):1011-1016. PubMed ID: 38620997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Green Closed-Loop Supply Chain Network Design During the Coronavirus (COVID-19) Pandemic: a Case Study in the Iranian Automotive Industry.
    Abbasi S; Daneshmand-Mehr M; Ghane Kanafi A
    Environ Model Assess (Dordr); 2023; 28(1):69-103. PubMed ID: 36540109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive approach to the design of ethanol supply chains including carbon trading effects.
    Giarola S; Shah N; Bezzo F
    Bioresour Technol; 2012 Mar; 107():175-85. PubMed ID: 22225607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.